FDA Has No Objection to PureCircle Reb D Stevia Sweetener

CHICAGOPureCircle announced the U.S. Food and Drug Administration (FDA) has issued a No Objection" letter for the use of PureCircles Rebaudioside D (Reb D) as a general purpose sweetener for foods and beverages in the United States. PureCircle research has identified high purity Reb D as having one of the best sweetness profiles of any steviol glycoside from the stevia leaf.

The GRAS confirmation of PureCircles Reb D arrives on the heels of the companys GRAS submission for Rebaudioside X (Reb X,) and builds on the companys track record for bringing the latest stevia innovation to the market. With GRAS affirmation, PureCircle is prepared for immediate commercialization of Reb D.

We have invested over $300 million in a supply chain infrastructure capable of delivering breakthrough ingredient innovation. We are proud to now work with our customers to turn this investment into breakthrough food and beverage solutions," said Jason Hecker, vice president global marketing & innovation, PureCircle.